Form 4 for RMD ResMed|
Accepted 2023-05-10 00:00:00 ET · period of report 2023-05-09 · accession 0001127602-23-015146 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-10 | 2023-05-09 | RMD | Sandercock Brett | CFO | S - Sale | $232.05 | -3,426 | 103.5K | -3% | -$795.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2023-05-09 | S | D | 3,426 | $232.05 | 103,516 | D | — | — | (F2) Includes 62.3215 shares of ResMed stock purchased on April 28, 2023, through the ResMed Employee Stock Purchase Plan. |